Presentation THT 2024 The Pivotal ALIVE Trial of the Revivent TC Transcatheter Ventricular Enhancement System in Heart Failure Patients with Prior Anterior Myocardial Infarction Presenter: Jerry D. Estep March 05, 2024
Presentation THT 2023 Regional LV Function Changes Following Revivent TC® Therapy Presenter: Horst Sievert March 21, 2023
Presentation THT 2023 Revivent TC® Procedure Planning and Anchor Placement Strategies Presenter: Patrick Klein March 21, 2023
Presentation THT 2023 Revivent TC® Patient Screening and Monitoring GDMT Response Presenter: Michael Pfeiffer March 21, 2023
News Daily News Hybrid Approach to Reshaping Left Ventricle Offers Hope for HF Patients L.A. McKeown December 06, 2019
Presentation TCT 2018 Treatment of LV Aneurysms: Revivent Presenter: James E. Udelson, Clyde W. Yancy, Horst Sievert September 22, 2018
News Industry News BioVentrix Receives CE Marking Certification for Revivent TC™, the First Minimally Invasive Heart Failure Treatment to Restore the Left Ventricle June 27, 2016
News Industry News BioVentrix Announces Successful First-In-Man, Catheter-Based Endovascular Clinical Procedure May 17, 2016
News Industry News BioVentrix Announces Successful First-In-Man, Catheter-Based Endovascular Clinical Procedure with Revivent-TC™ System for Heart Failure Treatment May 16, 2016
News Industry News BioVentrix Announces 30th Clinical Case Milestone for Revivent-TC™ Technology December 13, 2015